I. Sugo

Human Liver Cancer Glypican 3 Antibody as a Potential Antitumor Agent for − Anti

H. Aburatani, T. Kodama, M. Tsuchiya, 2008 .

Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.

T. Kamiyama, Y. Ohba, I. Sugo, 1999, Journal of cardiovascular pharmacology.

Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.

H. Aburatani, T. Kodama, M. Tsuchiya, 2008, Cancer research.

Synthesis and antihypertensive activity of KC-399, a benzopyran K+ channel opener with long duration of action and less tachycardia

Haruhiko Sato, H. Koga, Tadakatsu Takahashi, 1993 .

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

M. Tsuchiya, T. Igawa, H. Tsunoda, 2010, Anti-cancer drugs.

N,N-disubstituted benzopyran-4-(N′-cyano)carboxamidines, cromakalim analogs with selective activity for guinea pig trachealis

Haruhiko Sato, H. Koga, Imagawa Jun-ichi, 1993 .

In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.

S. Yoshida, T. Koga, J. Imagawa, 1994, The Journal of pharmacology and experimental therapeutics.